Form 8-K - Current report:
SEC Accession No. 0001193125-25-067901
Filing Date
2025-03-31
Accepted
2025-03-31 08:36:21
Documents
60
Period of Report
2025-03-31
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d848914d8k.htm   iXBRL 8-K 28041
2 EX-99.1 d848914dex991.htm EX-99.1 37756
3 EX-99.2 d848914dex992.htm EX-99.2 46936
7 GRAPHIC g848914ex99_2p10g1.jpg GRAPHIC 59922
8 GRAPHIC g848914ex99_2p11g1.jpg GRAPHIC 239528
9 GRAPHIC g848914ex99_2p12g1.jpg GRAPHIC 239467
10 GRAPHIC g848914ex99_2p13g1.jpg GRAPHIC 73471
11 GRAPHIC g848914ex99_2p14g1.jpg GRAPHIC 215716
12 GRAPHIC g848914ex99_2p15g1.jpg GRAPHIC 244255
13 GRAPHIC g848914ex99_2p16g1.jpg GRAPHIC 71052
14 GRAPHIC g848914ex99_2p17g1.jpg GRAPHIC 156066
15 GRAPHIC g848914ex99_2p18g1.jpg GRAPHIC 190274
16 GRAPHIC g848914ex99_2p19g1.jpg GRAPHIC 160904
17 GRAPHIC g848914ex99_2p1g1.jpg GRAPHIC 344704
18 GRAPHIC g848914ex99_2p20g1.jpg GRAPHIC 246325
19 GRAPHIC g848914ex99_2p21g1.jpg GRAPHIC 71200
20 GRAPHIC g848914ex99_2p22g1.jpg GRAPHIC 411621
21 GRAPHIC g848914ex99_2p23g1.jpg GRAPHIC 254088
22 GRAPHIC g848914ex99_2p24g1.jpg GRAPHIC 286657
23 GRAPHIC g848914ex99_2p25g1.jpg GRAPHIC 291043
24 GRAPHIC g848914ex99_2p26g1.jpg GRAPHIC 258912
25 GRAPHIC g848914ex99_2p27g1.jpg GRAPHIC 78045
26 GRAPHIC g848914ex99_2p28g1.jpg GRAPHIC 255242
27 GRAPHIC g848914ex99_2p29g1.jpg GRAPHIC 172610
28 GRAPHIC g848914ex99_2p2g1.jpg GRAPHIC 468190
29 GRAPHIC g848914ex99_2p30g1.jpg GRAPHIC 264164
30 GRAPHIC g848914ex99_2p31g1.jpg GRAPHIC 87670
31 GRAPHIC g848914ex99_2p32g1.jpg GRAPHIC 251290
32 GRAPHIC g848914ex99_2p33g1.jpg GRAPHIC 151976
33 GRAPHIC g848914ex99_2p34g1.jpg GRAPHIC 193835
34 GRAPHIC g848914ex99_2p35g1.jpg GRAPHIC 256866
35 GRAPHIC g848914ex99_2p36g1.jpg GRAPHIC 327492
36 GRAPHIC g848914ex99_2p37g1.jpg GRAPHIC 86585
37 GRAPHIC g848914ex99_2p38g1.jpg GRAPHIC 254676
38 GRAPHIC g848914ex99_2p39g1.jpg GRAPHIC 248676
39 GRAPHIC g848914ex99_2p3g1.jpg GRAPHIC 478917
40 GRAPHIC g848914ex99_2p40g1.jpg GRAPHIC 174649
41 GRAPHIC g848914ex99_2p41g1.jpg GRAPHIC 203327
42 GRAPHIC g848914ex99_2p42g1.jpg GRAPHIC 95959
43 GRAPHIC g848914ex99_2p43g1.jpg GRAPHIC 60321
44 GRAPHIC g848914ex99_2p44g1.jpg GRAPHIC 240298
45 GRAPHIC g848914ex99_2p4g1.jpg GRAPHIC 148112
46 GRAPHIC g848914ex99_2p5g1.jpg GRAPHIC 106698
47 GRAPHIC g848914ex99_2p6g1.jpg GRAPHIC 327437
48 GRAPHIC g848914ex99_2p7g1.jpg GRAPHIC 518937
49 GRAPHIC g848914ex99_2p8g1.jpg GRAPHIC 227301
50 GRAPHIC g848914ex99_2p9g1.jpg GRAPHIC 109613
51 GRAPHIC g848914g0331124304099.jpg GRAPHIC 4137
  Complete submission text file 0001193125-25-067901.txt   13498833

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pcvx-20250331.xsd EX-101.SCH 2850
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pcvx-20250331_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pcvx-20250331_pre.xml EX-101.PRE 11261
62 EXTRACTED XBRL INSTANCE DOCUMENT d848914d8k_htm.xml XML 3627
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39323 | Film No.: 25789090
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)